Arca Biopharma | ABIO - Market Capitalization


Arca Biopharma reported $1.02B in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alterity Therapeutics Limited AUD 36M 20M Jun/2026
Amgen USD 189.89B 13.64B Mar/2026
Arca Biopharma USD 1.47B 537M Dec/2025
Biogen USD 26.9B 1.09B Mar/2026
Brainstorm Cell Therapeutics USD 8M 3M Sep/2025
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Capricor Therapeutics USD 1.66B 1.33B Dec/2025
Cipla INR 988.89B 231.9B Mar/2026
Clal Biotechnology ILS 43.45M 8.92M Mar/2026
CSL USD 55.89B 20.42B Dec/2025
Cytokinetics USD 8.19B 420M Mar/2026
Gilead Sciences USD 172.99B 20.71B Mar/2026
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
Laboratory Of America USD 21.93B 1.13B Mar/2026
Otsuka Holdings JPY 5.98T 1.16T Mar/2026
Pfizer USD 153.81B 12.24B Mar/2026
United Therapeutics USD 25.19B 4.21B Mar/2026